BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1740 related articles for article (PubMed ID: 9861628)

  • 1. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ; Wiśniewski K
    Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats.
    Fiedorowicz RJ; Wiśniewski K
    Pol J Pharmacol Pharm; 1989; 41(6):573-83. PubMed ID: 2577226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ; Wiśniewski K
    Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of C-terminal cholecystokinin fragments in the circulatory system of rats.
    Wiśniewska RJ; Kupryszewski G
    Pol J Pharmacol Pharm; 1992; 44(3):281-7. PubMed ID: 1470565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central action of drugs influencing beta-adrenergic receptor. part V. The interaction of drugs affecting beta-adrenergic receptor in motility test.
    Ksiaz A; Kleinrok Z
    Pol J Pharmacol Pharm; 1975; 27(6):595-601. PubMed ID: 1714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-adrenoceptors on the behaviour induced by the neuropeptide glutamic acid isoleucine amide.
    Sánchez-Borzone ME; Attademo A; Baiardi G; Celis ME
    Eur J Pharmacol; 2007 Jul; 568(1-3):186-91. PubMed ID: 17537427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the adrenergic drugs on the electrical responses of the rabbit isolated heart atrium.
    Smejkal V; Mironneau J; Ojeda C; Gargouil YM
    Physiol Bohemoslov; 1970; 19(1):19-22. PubMed ID: 4394505
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular effects of tyramine: adrenergic and cholinergic interactions.
    Khwanchuea R; Mulvany MJ; Jansakul C
    Eur J Pharmacol; 2008 Jan; 579(1-3):308-17. PubMed ID: 18036584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of alpha and beta blocker properties of parahydroxybenzonitrile on the cardiovascular system of rats].
    Cheav SL; Kirkiacharian S; Piéri F; Poisson D
    Ann Pharm Fr; 1998; 56(5):205-8. PubMed ID: 9805819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of autonomic blockade on non-linear cardiovascular variability indices in rats.
    Beckers F; Verheyden B; Ramaekers D; Swynghedauw B; Aubert AE
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):431-9. PubMed ID: 16700875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.
    Mutafova-Yambolieva V; Staneva-Stoytcheva D
    Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):551-7. PubMed ID: 2906393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholaminergic regulation of the hypothalamic-pituitary-adrenocortical activity.
    Bugajski J; Turoń M; Gadek-Michalska A; Borycz JA
    J Physiol Pharmacol; 1991 Mar; 42(1):93-103. PubMed ID: 1681965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of beta-adrenoceptors in a central regulation of the ovarian progesterone release in rats.
    De Bortoli MA; Garraza MH; Aguado LI
    Neuro Endocrinol Lett; 2002 Feb; 23(1):27-31. PubMed ID: 11880859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional involvement of vasopressin in the maintenance of systemic arterial blood pressures after phenoxybenzamine or phentolamine administration: studies in Long-Evans and Brattleboro rats.
    Winn MJ; Gardiner SM; Bennett T
    J Pharmacol Exp Ther; 1985 Nov; 235(2):500-5. PubMed ID: 2865355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotransmitter-mediated control of neuronal firing in the red nucleus of the rat: reciprocal modulation between noradrenaline and GABA.
    Ciranna L; Licata F; Li Volsi G; Santangelo F
    Exp Neurol; 2000 May; 163(1):253-63. PubMed ID: 10785465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J; Zhang LF; Han C; Yu GS; Ma J
    J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors.
    Armour JA
    Can J Cardiol; 1997 Mar; 13(3):277-84. PubMed ID: 9117916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.